Recro Pharma
REPH
#8571
Rank
S$0.16 B
Marketcap
$2.81
Share price
-0.48%
Change (1 day)
-28.33%
Change (1 year)

Revenue for Recro Pharma (REPH)

Revenue in 2021 (TTM): S$0.10 Billion

According to Recro Pharma 's latest financial reports the company's current revenue is S$0.10 Billion. In 2020 the company made a revenue of S$89.25 Million a decrease over the revenue in the year 2019 that were of S$0.13 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Recro Pharma from 2016 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)S$0.10 B14.1%
2020S$89.25 M-32.98%
2019S$0.13 B28.28%
2018S$0.10 B7.67%
2017S$96.41 M3.6%
2016S$93.06 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
S$117.70 B 116,269.43%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.13 B 33.23%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.92 B 816.02%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.87 M-99.14%๐Ÿ‡บ๐Ÿ‡ธ USA
S$14.75 M-85.41%๐Ÿ‡บ๐Ÿ‡ธ USA